Navigation Links
Food insecurity linked to HIV-treated drug users' deaths
Date:5/31/2013

Food insecurity increases the risk of death among injection drug users living with HIV/AIDS even when they are receiving life-prolonging antiretroviral therapy (ART), according to a new study involving Simon Fraser University.

The study, recently published in the peer-reviewed science journal, PLoS One, examines the impact of food insecurity and hunger on survival among injection drug users. Food insecurity is defined by the United Nations' World Food Programme as having insufficient access to adequate quantity and quality of food. Researchers found that drug users who were food insecure when first initiating ART were twice as likely to die compared to individuals who were food secure.

"This is the first study to look at the impact of food insecurity on the survival of HIV-positive injection drug users," says senior author Robert Hogg, an SFU health sciences professor and director of the HIV/AIDS Drug Treatment Program at the BC Centre for Excellence in HIV/AIDS (BC-CfE).

Hogg is responsible for the B.C. portion of a national HIV food security study, which this paper advances.

"The introduction of life-saving antiretroviral therapy has significantly reduced HIV-related morbidity and mortality, however, the impact of insufficient access to food, particularly quality food, on the mortality of HIV-positive injection drug users is alarming. This research points to the urgent need to further investigate the impact of food insecurity on the health outcomes of people living with HIV/AIDS."

Researchers followed 254 injection drug users across B.C., finding that 71 per cent of them reported being food insecure at the time of ART initiation. After 13 years of follow-up, drug users who were food insecure were twice as likely to die compared to individuals who were food secure. Sub-analyses found hunger, or food insufficiency, was not the primary cause of mortality in this population.

"Findings regarding the relationship between food inse
'/>"/>

Contact: Carol Thorbes
cthorbes@sfu.ca
778-782-3035
Simon Fraser University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Exposure to antibiotics linked to severity of allergic asthma: UBC research
2. Autism risk gene linked to differences in brain structure
3. Spontaneous gene glitches linked to autism risk with older dads
4. Dental X-rays linked to common brain tumor
5. Ocean acidification linked to larval oyster failure
6. First mass extinction linked to marine anoxia
7. Prenatal exposure to air pollution linked to childhood obesity
8. Knee injuries in women linked to motion, nervous system differences
9. Researchers discover first gene linked to missing spleen in newborns
10. Air pollution level changes in Beijing linked with biomarkers of cardiovascular disease
11. University of Leicester study finds low agreeableness linked to a preference for aggressive dogs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Growing need for data security ... projects to drive India biometrics market ... report, " India Biometrics Market Forecast & Opportunities, 2020 ", ... to grow at a CAGR of over 35% during 2015 ... of extensive use of biometric technology in the government sector. ...
(Date:8/31/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/st5b3m/saudi_arabia ) has announced ... Market - Growth, Trends & Forecasts (2014-2020)" report ... Biomedical Sensors market is estimated at $0.23 billion by ... 2014-2020 The near future will bring biomedical ... each individual. These sensors can be set to trigger ...
(Date:8/28/2015)... August 28, 2015 According to ... Market by Assessment Type (Pen & Paper Based, Hosted, ... Corporate Learning, Academic Research), Vertical and Region - Global ... Training Market to grow from USD 2.4 Billion in ... Compound Annual Growth Rate (CAGR) of 25.6% from 2015 ...
Breaking Biology News(10 mins):India Biometrics Market to Grow at Over 35% Through 2020, Says TechSci Research 2India Biometrics Market to Grow at Over 35% Through 2020, Says TechSci Research 3Saudi Arabia Biomedical Sensors Market Report 2015 - Growth, Trends & Forecasts (2014-2020) 2Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 2Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 3Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 4
... at the Smithsonian,s National Zoo detected a secondary rise ... panda Mei Xiang (may-SHONG) earlier this month. The results ... to believe the hormone rise indicates that it would ... birth to a cub or comes to the end ...
... 20, 2008) The future of high-intensity x-ray science ... Department of Energy,s Argonne National Laboratory have devised a ... free electron laser oscillator (X-FELO) we are proposing can ... than currently operating machines," Argonne Distinguished fellow Kwang-Je Kim ...
... as temperatures warm along the East Coast of the ... less likely they are to keep pace with the ... the Manomet Center for Conservation Sciences analyzed changes in ... birds along the coast of eastern Massachusetts since 1970. ...
Cached Biology News:A novel X-ray source could be brightest in the world 2Birds migrate earlier, but some may be left behind as the climate warms rapidly 2
(Date:8/31/2015)... 31, 2015 Research and Markets ( http://www.researchandmarkets.com/research/53wxp3/israel_biomedical ... Biomedical Sensors Market - Growth, Trends & Forecasts (2014-2020)" ... Israel Biomedical Sensors market is estimated at $0.19 billion ... period 2014-2020 The near future will bring ... of each individual. These sensors can be set to ...
(Date:8/31/2015)...  For people with Down syndrome, news from ... company, located in the Science + Technology Park at ... therapies yet for people with Down syndrome and other chromosome ... syndrome and Edwards syndrome aneuploidies in human cell cultures, ... Elixirgen plans to develop this technology into a treatment ...
(Date:8/31/2015)... MARLBOROUGH, Mass. , Aug. 31, 2015 /PRNewswire/ ... biotechnology company focused on discovering and developing innovative ... ophthalmology, today announced that the 30-day review period ... Drug (IND) for ocular indications with the U.S. ... the IND is now active. ...
(Date:8/31/2015)... and SHANGHAI , Aug. ... biopharmaceutical company developing next-generation antibiotics, today announced positive ... study for its lead drug candidate MRX-I. MRX-I ... drug-resistant bacteria such as MRSA and VRE, while ... tolerated therapeutic option than currently available oxazolidinone agents. ...
Breaking Biology Technology:Israel Biomedical Sensors Market 2015 - Growth, Trends & Forecasts to 2020 2New Down syndrome therapy discovered 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 3RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 4MicuRX Reports Positive Top-Line Results In Phase 2 Clinical Trial For Novel Antibiotic MRX-I In Complicated Skin And Soft Tissue Infections 2
... , , ... Corporation (Pink Sheets: CGCP), a market leader in laser transmyocardial ... (Investigational Device Exemption) to the Food and Drug Administration to ... with refractory angina. The PHOENIX Combination Delivery System combines ...
... TAINAN, Taiwan, July 30 /PRNewswire-Asia/ -- Eli Lilly ... today that they have,reached an amicable resolution of ... ScinoPharm,s manufacture and sale of gemcitabine,hydrochloride around the ... of the settlement, Lilly has granted ScinoPharm a ...
... LAUSANNE, Switzerland and MEDFORD, Massachussets, July 30 ... companies with a focus on the development of ... Protein Technologies (MSM), a human,antibody drug discovery company ... announce the signature of an exclusive,agreement for the ...
Cached Biology Technology:Cardiogenesis Corporation Makes Pre-IDE Submission for PHOENIX Combination Delivery System 2Eli Lilly & Company and ScinoPharm Taiwan Ltd. Announce Settlement of Gemcitabine Litigation 2Debiopharm and MSM Protein Technologies Sign Agreement for Research and Development of Debio 0929, a Novel Oncology Biologic 2Debiopharm and MSM Protein Technologies Sign Agreement for Research and Development of Debio 0929, a Novel Oncology Biologic 3Debiopharm and MSM Protein Technologies Sign Agreement for Research and Development of Debio 0929, a Novel Oncology Biologic 4